← TrialMatch
HomeTrials

The Effect of Dual-task Training on Balance, Exercise Capacity, Cognitive Status, and Qual

The aim of this study is to investigate the effects of dual-task training on balance, exercise capacity, cognitive function, and quality of life in individuals with Type 2 Diabetes Mellitus (DM). As a result of this study, it is hoped that dual-task training will be an alternative to single-task training in the rehabil

Condition(s)Diabetes Mellitus, Type 2
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe aim of this study is to investigate the effects of dual-task training on balance, exercise capacity, cognitive function, and quality of life in individuals with Type 2 Diabetes Mellitus (DM). As a result of this study, it is hoped that dual-task training will be an alternative to single-task training in the rehabilitation of individuals with Type 2 DM, with the goal of preventing falls and supporting a more active lifestyle. Additionally, it is intended to include dual-task training in preventive physiotherapy approaches. The main questions the study aims to answer are as follows: Is dual-task training, conducted concurrently with exercise training, more effective in improving balance when compared to exercise training alone and the control group? Is dual-task training, conducted concu
Who can participateInclusion Criteria: * Being followed up with a diagnosis of Type 2 Diabetes Mellitus for at least 6 months (fasting plasma glucose of 7.0 mmol/L or higher) * Not having participated in any structured exercise program for at least 6 months prior. * Being willing to volunteer for the study Exclusion Criteria: * Nephropathy * Retinopathy * Having dementia or Alzheimer's disease * Using a walking aid * Having ulceration * Using balance-curing drugs * Surviving myocardial infarction at least 6 months ago * Stable or unstable angina pectoris * Left ventricular ejection fraction below 40% * Peripheral arterial diseases * Resting blood pressure above 160/100 mmHg * Body mass index above 35 kg/m2 * Having a history of deep vein thrombosis, pulmonary embolism or stroke in the past
Ages65 Years
SexAll
Lead sponsorBartın Unıversity
LocationsBartın, Turkey (Türkiye)
Start date2024-12-25
NCT IDNCT06721429
Official listinghttps://clinicaltrials.gov/study/NCT06721429

🔍 Search all trials →